May 13, 2024
“Just 4% of today’s retirees said they are “living the dream,” according to a new survey from asset management company Schroders. And just as many — 4% — said they are “living the nightmare.” Most of the respondents fall somewhere in between… Continue Reading…
February 13, 2023
“…The strong rally across the major indices so far this year has surprised many market watchers, especially given that the Federal Reserve is hot off another interest rate hike as it continues to try and combat nagging inflation. Several Fed… Continue Reading…
September 19, 2022
“…According to Investor’s Business Daily, this led the stock market to plunge to its worst one-day loss since June 2020, with total losses of over $1 trillion dollars. But does that mean you should run to your brokerage account and buy… Continue Reading…
June 29, 2021
“Day One Biopharmaceuticals (DAWN)… Overall, there is broad agreement on Wall Street with Rama’s view, as indicated by the unanimous Strong Buy consensus rating, supported by 4 recent positive reviews. Shares in DAWN are selling for $20.11 and their $37.33 average… Continue Reading…
March 26, 2021
“BorgWarner, Inc. (BWA)… Brinkman is not an outlier in his bullish stance, but there is some division on Wall Street regarding BWA. The analyst consensus view is a Moderate Buy, based on 14 recent reviews breaking down to 8 Buys, 5… Continue Reading…
December 21, 2020
“Lordstown Motors (RIDE)… Overall, RIDE shares get a Hold from the analyst consensus, reflecting Wall Street caution toward a new – and highly speculative – endeavor. The rating is derived from 4 recent reviews, evenly split between 2 Buys and 2… Continue Reading…
October 6, 2020
“Coster remains positive on Nikola and keeps an Overweight (i.e. Buy) rating along with a bullish $41 price target. The analyst, therefore, expects shares to add nearly 70% from current levels… Nikola appears to be the subject of much head… Continue Reading…
September 26, 2020
“NexTier Oilfield Solutions (NEX)… Similarly, the rest of the Street is getting onboard. 6 Buy ratings and 2 Hold assigned in the last three months add up to a Strong Buy analyst consensus. In addition, the $3.70 average price target… Continue Reading…
September 16, 2020
“MediWound Ltd. (MDWD)… To this end, DeGeeter rates MDWD an Outperform along with a $7 price target. Should his thesis play out, a potential twelve-month gain of 117% could be in the cards… UroGen Pharma (URGN)… To this end, Gershell… Continue Reading…
September 2, 2020
“This summer didn’t just see temperatures heat up. The S&P 500 has been on fire, with the index breaking record after record during the month of August and now sitting at 3,526.65 points. As its 2020 S&P 500 price target… Continue Reading…
Recent Comments